Nevertheless, several dirty drugs that aim for multiple targets at once are clinically effective in the treatment of complex diseases [240, 241], which might also underscore the therapeutic potential of the AP-2β for complex MNDs like obesity and neuroblastoma. The gene discussed is TFAP2B; the disease is Obesity.